MCRB icon

Seres Therapeutics
MCRB

Overview Fund Activity

70 hedge funds and large institutions have $143M invested in Seres Therapeutics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 7 closing their positions.

Holders
70
Holders Change
-2
Holders Change %
-2.78%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
21
Reduced
27
Closed
7
Calls
$4K
Puts
$124K
Net Calls
-$120K
Net Calls Change
-$192K

Top Buyers

1
AIM
1
ARK Investment Management
Florida
$18.6M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$3.64M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$145K
4
Russell Investments Group
4
Russell Investments Group
United Kingdom
$101K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$82K

Top Sellers

1
RSCM
1
Rock Springs Capital Management
Maryland
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.85M
3
CEP
3
Chicago Equity Partners
Illinois
$0
4
PP
4
Paloma Partners
Connecticut
$0
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$7.86M
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– – – –
Group One Trading
77
Group One Trading
Illinois
– – – –
Wolverine Trading
78
Wolverine Trading
Illinois
– – – –
AAMU
79
Amundi Asset Management US
Massachusetts
$0 25 – –
PNC Financial Services Group
80
PNC Financial Services Group
Pennsylvania
$0 48 – –
SQA
81
Simon Quick Advisors
New Jersey
$0 20 +20 New
1 2 3
4